Facebook tracking pixel
S10.AI
ICD-10-CM · F03.91GeneralSystemic

Agitated Dementia

Understanding Agitated Dementia: Find information on dementia with agitation, including behavioral disturbance in dementia. This resource covers clinical documentation, medical coding, healthcare guidelines, and best practices for diagnosing and managing agitated dementia. Learn about symptoms, assessment, and treatment strategies for improved patient care.

Also known as
Dementia with AgitationBehavioral Disturbance in Dementia
Definition

A decline in cognitive function with significant behavioral changes like restlessness, aggression, or wandering.

Clinical signs

Memory loss, confusion, difficulty with daily tasks, plus agitation, irritability, and emotional outbursts.

Common settings

Nursing homes, assisted living facilities, memory care units, and sometimes at home with caregiver support.

Related Codes

ICD-10 Code Families

Complete code families applicable to F03.91

F02-F09
Dementia in other diseases
F01-F01
Vascular dementia
G30-G30
Alzheimers disease
F60-F69
Personality and behavioral disorders
Code Comparison

When to use each related code

DescriptionWhen to use
Dementia with disruptive behaviors.Agitated Dementia (A) if prominent agitation impacts care, document specific behaviors.
General term for cognitive decline.Dementia NOS if type is unspecified or mixed, further workup needed. Consider Major Neurocognitive Disorder.
Dementia caused by vascular disease.Vascular Dementia if cognitive decline follows cerebrovascular events, confirm with imaging.
Documentation

Best-practice checklist

  • Document specific agitated behaviors (e.g., pacing, verbal outbursts).
  • Note frequency, duration, and severity of agitation.
  • Assess for underlying medical causes of agitation.
  • Document impact on patient's function and safety.
  • Record non-pharmacological and pharmacological interventions.
Coding & Audit Risks

Common pitfalls to avoid

Unspecified Dementia Type

Coding Agitated Dementia without specifying the underlying dementia type (e.g., Alzheimer's) can lead to rejected claims and inaccurate severity reflection.

Symptom vs. Diagnosis Coding

Incorrectly coding agitation symptoms separately, rather than using the combination code for Agitated Dementia, can lead to overcoding and compliance issues.

Lack of Supporting Documentation

Insufficient documentation of behavioral disturbances and cognitive decline can result in claim denials and difficulty in justifying the Agitated Dementia diagnosis.

Mitigation

Best-practice tips

  • 011. CDI: Document agitation specifics (frequency, triggers). ICD-10: F02.81
  • 022. Compliance: Prioritize non-pharmacological interventions. CMS guidelines.
  • 033. Coding: Code underlying dementia type + agitation codes. G30.9, F02.81
  • 044. CDI: Assess for pain, discomfort, infection as triggers. Review MAR.
  • 055. Compliance: Regularly review/adjust medications for efficacy and safety.
Clinical Decision Support

Step-by-step checklist

  1. 1

    1. Verify dementia diagnosis (e.g., F00-F03, G30, G31.1) documented.

  2. 2

    2. Confirm agitation symptoms: aggression, restlessness, irritability.

  3. 3

    3. Assess for contributing factors: pain, infection, medication side effects.

  4. 4

    4. Rule out delirium (F05), other psychiatric disorders (F06-F99).

Documentation Template

Ready-to-paste narrative

Patient presents with symptoms consistent with a diagnosis of Agitated Dementia (also known as Dementia with Agitation or Behavioral Disturbance in Dementia).  The patient exhibits a progressive decline in cognitive function, including memory impairment, impaired judgment, and difficulty with executive functioning.  These cognitive deficits are accompanied by significant agitation, manifested as restlessness, pacing, verbal outbursts, and resistance to care.  The patient's behavioral disturbances are impacting their safety and quality of life, as well as posing challenges for caregivers.  Differential diagnoses considered included delirium, depression, and medication side effects.  These were ruled out based on clinical presentation, laboratory results, and review of the patient's medication history.  The patient's Mini-Mental State Examination (MMSE) score is [Insert Score], indicating [Severity of Cognitive Impairment].  Assessment for underlying medical conditions contributing to agitation, such as pain, infection, or metabolic imbalances, is negative.  Non-pharmacological interventions, including environmental modifications and behavioral therapies, will be implemented.  Pharmacological management with [Medication Name and Dosage] is being initiated to target the agitation symptoms.  The patient's family has been educated on the diagnosis, prognosis, and management strategies for Agitated Dementia.  Follow-up appointments are scheduled to monitor symptom progression, medication effectiveness, and caregiver burden.  ICD-10 code F02.81 (Dementia in other diseases classified elsewhere with behavioral disturbance) is documented for medical billing and coding purposes.  Continued assessment and adjustment of the treatment plan will be based on the patient's response and evolving needs.
FAQs

Common questions and answers

What are the most effective non-pharmacological interventions for managing agitation in patients with a diagnosis of agitated dementia?+

Non-pharmacological interventions are often the first line of treatment for agitation in dementia. These approaches aim to address underlying triggers and improve the patient's quality of life. Some of the most effective strategies include creating a calm and structured environment, incorporating personalized activities that cater to the patient's remaining abilities and interests, and employing behavioral modification techniques such as positive reinforcement. Sensory stimulation therapies, like music or aromatherapy, can also be beneficial. Furthermore, caregiver education and support are crucial for consistent implementation and success. Explore how a multidisciplinary approach, involving occupational therapy, social work, and caregiver training, can optimize outcomes for patients with agitated dementia. Consider implementing regular assessments to monitor the effectiveness of these interventions and adjust the care plan as needed.

How can I differentiate between agitation caused by dementia and delirium in a geriatric patient presenting with behavioral disturbances?+

Differentiating between agitation related to dementia and delirium requires careful assessment of the patient's history, cognitive status, and overall clinical picture. Delirium typically has a rapid onset, fluctuating course, and is often associated with an identifiable medical cause such as an infection or medication side effect. In contrast, agitation in dementia tends to develop more gradually and is a core feature of the disease process. Key distinguishing factors include the presence of altered consciousness, attention deficits, and perceptual disturbances, which are more prominent in delirium. Thorough physical examination, laboratory tests, and review of medications are crucial to identify potential underlying medical conditions. Learn more about validated assessment tools, like the Confusion Assessment Method (CAM), to aid in accurate diagnosis and guide appropriate management strategies. Consider implementing standardized protocols to ensure consistent and timely assessment of patients presenting with behavioral disturbances.

When is pharmacological intervention warranted for agitated dementia, and what are the preferred first-line agents considering potential side effects in elderly patients?+

Pharmacological interventions for agitated dementia should be considered when non-pharmacological approaches have been inadequate or the patient poses a risk to themselves or others. The choice of medication should be individualized based on the patient's specific symptoms, comorbidities, and potential for drug interactions. While antipsychotics are sometimes used, they should be prescribed cautiously in elderly patients due to the increased risk of serious side effects such as stroke and falls. Other options, such as mood stabilizers and certain antidepressants, may be considered depending on the underlying cause of the agitation. Careful monitoring of medication effectiveness and side effects is essential. Explore how alternative therapies, such as cholinesterase inhibitors or memantine for cognitive symptoms, can potentially reduce the need for antipsychotics. Consider implementing a stepped-care approach, starting with non-pharmacological interventions and gradually escalating to medication if necessary, while continuously reevaluating the patient's response.

Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.

Coding standard: ICD-10-CM, current FY guidelines.